Our CEO Kevin Caldwell recently joined Ira S. Pastor on the Progress, Potential, And Possibilities podcast to discuss how Ossium is advancing stem cell science to improve patient outcomes and build a healthier future. Listen to the conversation here: https://lnkd.in/gDQQjrsP
关于我们
Our mission is to improve the health, vitality, and longevity of human beings through bioengineering. Who we are: At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good. Values we live by: Impact We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive positive change. Truth Embracing the truth empowers us to learn from both our successes and our mistakes. We follow the data wherever it leads. Ownership We hold ourselves and each other to the highest bar. We care deeply about the work we do. Grit Each obstacle we encounter in pursuit of a healthier future only sharpens our resolve. We understand that our vision is worth fighting for.
- 网站
-
https://www.ossiumhealth.com/
Ossium Health的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Francisco，California
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Bone marrow banking、Cryopreservation、Stem cell biology、Research、Stem Cell Therapy、Stem Cell Transplant、Bone Marrow Transplant和Orthopedic products
地点
Ossium Health员工
动态
-
Great feature in The Scientist on how Ossium’s bone marrow banking platform is transforming stem cell transplantation and expanding access for patients in need! Read more: https://lnkd.in/gDMi8KEE
-
We’re in Honolulu this week to exhibit at #Tandem2025! Join us at Booth 629 as we share exciting updates on how our bone marrow banking platform has already provided new options for stem cell transplant recipients through our PRESERVE I study and expanded access program. Read more here: https://lnkd.in/gzi9cQUS
-
Cell & Gene reached out to industry leaders, including Ossium’s CEO Kevin Caldwell, for predictions on what 2025 holds for biopharma. Watch the roundtable discussion here ??
-
?? On the latest episode of the Russo Edge Podcast, host solomon wilcots of Russo Partners interviews Kevin Caldwell, CEO, Co-founder and President of Ossium Health, who covers some of the hurdles faced by companies with innovative healthcare solutions. Kevin speaks about bridging the divide from bench to bedside and bringing things from a small scale at the early stage to high production levels and out into the world. Barriers and obstacles encountered, such as finding organ donors and building facilities capable of high production, are things encountered by entrepreneurs that can be overcome with grit and time. To listen to the episode, visit: https://bit.ly/4iho1PD Apple Podcasts: https://apple.co/41qddbJ Watch on YouTube: https://bit.ly/3ZPbM5x #Biotech #Biopharma #BoneMarrow #Translplants
-
In this article from First Round Capital, our CEO & Co-Founder Kevin Caldwell shares insight on how he reflects on past successes and failures to guide his decision-making. Check it out: https://lnkd.in/g8k_juvX
To lean into the introspective mood of this time of year, we asked founders: What are your go-to prompts for self-reflection? On The Review, we’ve compiled their responses into a list of 25 questions that founders can ask themselves to get more clarity at every step of the startup journey — from setting your daily to-do list to rethinking the product strategy to taking stock of your own growth as your company scales. Here are a few of our favorites: How can we make this product even more delightful? — Rahul Vohra, founder and CEO of Superhuman Where are we on the continuum of chaos and control? — Kareem Amin, co-founder and CEO of Clay Is my team missing any context to be able to make good decisions for the company? — Shensi Ding, co-founder and CEO of Merge If I was starting this business again today from scratch, what would I build to win the market? — Laura Behrens Wu, co-founder and CEO of Shippo If we close 100 more deals that are just like this one, will we be happy or sad? — Melissa Nightingale, co-founder of Raw Signal Group
-
-
We’re down in San Diego for some sunshine and the?American Society of Hematology Annual Meeting! Come visit us at booth 217 to hear more about how our organ donor bone marrow is already improving the availability, quality, and reliability of stem cell transplants for blood cancer patients #ASH24 #BMTSM https://lnkd.in/gEsU_GJu
-
-
Founder, TaskRabbit | Investor | Entrepreneur | Board Director | Host: Breaking Precedent ????/????
Kevin Caldwell is one of the smartest, kindest, and most visionary founders I have ever met. He is saving lives and transforming regenerative medicine. This conversation was a treat for me!
-
Join us tomorrow, Thursday, December 5th at 2:00pm ET for a webinar featuring "The Promise of Bone Marrow Banking" presented by Ossium Health. Kevin Caldwell, CEO, Co-Founder & President will present on organ donor-derived bone marrow bank to deploy hematopoietic stem cells for blood cancer treatment. Ossium sources bone marrow from the vertebral bodies of organ donors through its partnerships with 27 OPOs. Ossium’s bone marrow, referred to as “HPC, Marrow,” is processed and cryopreserved ensuring that transplantable units are available when patients need them most. Ossium Health is a Gold Level AOPO Industry Partner. Click here to register: https://lnkd.in/ehrHHGVe